Resuscitation
journal homepage: www.elsevier.com/locate/resuscitation
Clinical paper
a r t i c l e i n f o a b s t r a c t
Article history: Aim: Extracorporeal cardiopulmonary resuscitation (ECPR) has been shown to have survival benefit over
Received 29 July 2009 conventional CPR (CCPR) in patients with in-hospital cardiac arrest of cardiac origin. We compared the
Received in revised form 19 February 2010 survival of patients who had return of spontaneous beating (ROSB) after ECPR with the survival of those
Accepted 10 March 2010
who had return of spontaneous circulation (ROSC) after conventional CPR.
Methods: Propensity score-matched cohort of adults with in-hospital prolonged CPR (>10 min) of car-
Keywords:
diac origin in a university-affiliated tertiary extracorporeal resuscitation center were included in this
Cardiopulmonary resuscitation
study. Fifty-nine patients with ROSB after ECPR and 63 patients with sustained ROSC by CCPR were ana-
Extracorporeal membrane oxygenation
Return of spontaneous circulation
lyzed. Main outcome measures were survival at hospital discharge, 30 days, 6 months, and one year, and
Propensity score neurological outcome.
Cardiac arrest Results: There was no statistical difference in survival to discharge (29.1% of ECPR responders vs. 22.2% of
CCPR responders, p = 0.394) and neurological outcome at discharge and one year later. In the propensity
score-matched groups, 9 out of 27 ECPR patients survived to one month (33.3%) and 7 out of 27 CCPR
patients survived (25.9%). Survival analysis showed no survival difference (HR: 0.856, p = 0.634, 95% CI:
0.453–1.620) between the groups, either at 30 days or at the end of one year (HR: 0.602, p = 0.093, 95%
CI: 0.333–1.088).
Conclusions: This study failed to demonstrate a survival difference between patients who had ROSB after
institution of ECMO and those who had ROSC after conventional CPR. Further studies evaluating the role
of ECMO in conventional CPR rescued patients are warranted.
© 2010 Elsevier Ireland Ltd. All rights reserved.
0300-9572/$ – see front matter © 2010 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.resuscitation.2010.03.002
J.-W. Lin et al. / Resuscitation 81 (2010) 796–803 797
addressed this issue.11–16 Conducting a randomized trial in patients 2.4. Propensity score methods
who have just regained ROSC after CPR is difficult. Therefore,
instead, we tried to match the pre-arrest conditions of ECPR and Propensity score matching is a method used to balance observed
CCPR patients. The objective of the present study was to compare covariates in two treatment groups, e.g., ECPR and CCPR. In
survival and neurological outcomes between patients with sus- the present study, the propensity score was the conditional
tained ROSC after CCPR and those regaining return of spontaneous probability of receiving ECPR, as a binary-dependent variable,
(ventricular) beating (ROSB) after ECPR. under a set of measurements in patients with sustained ROSC
or ROSB after CPR.20 All baseline pre-arrest characteristics and
parameters potentially related to survival were incorporated
2. Methods into a logistic regression model as covariates. This matching
process made the observational studies simulate a random-
2.1. Clinical setting ized trial and reduced selection bias between the two study
groups.21
The study was conducted in a university-affiliated medical cen- In ROSB and ROSC responders, a number of parameters
ter with 227 intensive care beds. The CPR Team, consisting of a were investigated: age; sex; initial cardiac rhythm such as
senior resident, several other residents, a respiratory therapist, a ventricular tachycardia/ventricular fibrillation (VT/VF); pulseless
head nurse, and several registered nurses, was in charge of resus- electric activity (PEA) or asystole; CPR duration; the tim-
citation for in-hospital cardiac arrest (IHCA). From 2003 onward, ing and location in which the CPR occurred; presence of
each cardiac arrest event was recorded in a web-based database comorbidities (diabetes mellitus, hypertension, dyslipidemia, and
system.18,19 The accompanying CPR process was also entered into malignancy), chronic obstructive pulmonary disease (COPD),
the database and reviewed by the IHCA Task Force. The underlying pre-existing coronary artery disease or cerebrovascular disease
etiology causing the cardiac arrest and resulting in the resuscitation (CVAs); abnormal liver function; and chronic need for dialy-
was determined by the Task Force Committee.14 sis.
These parameters were combined into a non-parsimonious mul-
2.2. Data collection tivariable logistic regression model to predict the probability of the
use of ECPR. The predicted probability derived from the logistic
Adult IHCA victims receiving IHCPR from 2004 to 2006 were equation was then used as the propensity score for each individual
enrolled in the study. The inclusion criteria were the following: patient.
patients aged 18–75 years with circulatory arrest of cardiac origin,
as judged by two independent members in the IHCA Task Force 2.5. Study cohort assembly
committee.
Patients who underwent CCPR for >10 min for an arrest of ECPR and CCPR responders were pooled together and classified
proven cardiac origin were recruited as controls. Patients who according to their propensity scores in ascending order. They were
were considered for the use of extracorporeal CPR had prolonged matched by their propensity score in 1:1, 2:2, 3:3, and 4:4 blocks.
CPR (>10 min) without sustained ROSC. The definition of sus- Subjects that failed to find an appropriate match within the accept-
tained ROSC was continuous maintenance of the spontaneous able rank range were excluded from further analysis. Remaining
circulation for ≥20 min. The decision to call the ECMO team was patients constituted well-matched 1:1 extracorporeal-assisted CPR
made mainly by the attending doctors. Strict contraindications to responders and CCPR responders with equalized baseline prognos-
the use of ECMO included severe trauma, uncontrollable hem- tic factors.
orrhage, terminal malignancy, age >75 years, irreversible brain
damage, and signed consent for “do not attempt resuscitation.” 2.6. Endpoints
The equipment and management of ECMO has been previously
reported.14 The main component of the ECMO circuit was a The primary endpoint was survival to hospital discharge. The
heparin-bonded surface embedded in a centrifugal pump and secondary endpoint was survival at 30 days, 6 months, and 365
hollow-fiber oxygenation (Medtronic Incorporated, Ahaheim, CA, days. Neurological status was also assessed.
USA).
Only patients with arrests of proven cardiac etiology were 2.7. Statistical analysis
recruited as cases in the CCPR group and the ECPR group. In the
former, cases with sustained ROSC at the end of resuscitation were The comparison between the two selected groups was made
recruited for further analysis. In the ECPR group, we defined ROSB by hazard ratio, 95% confidence interval, and p values. Patients
after extracorporeal assistance, and then included cases with ROSB in the CCPR group who received extracorporeal support at a
only as the comparison group. ROSB in the ECPR group, in contrast later time were regarded as no ECMO support (on an inten-
to ROSC in the CCPR group, was maintained by artificial circulation. tion to treat basis). Survival duration was determined from the
The presence of atrial electrical activity without ventricular electric time of entry into the study to death or censorship at discharge,
activity was not considered ROSB. one month, and one year. The proportions of each group with
better neurological outcomes, defined as Cerebral Performance
Category score 1 or 2, were compared by 2 and odds ratio
2.3. Study design (OR).
A logistic regression model was used to carry out the propen-
We prospectively examined the survival difference between all sity match under SPSS 13.0 (SPSS Incorporated, Chicago, IL, USA).
patients in the ECPR group with ROSB (E-rosb) and all patients OR and 95% confidence intervals (95% CI) were used to repre-
the CCPR group with sustained ROSC (C-rosc). A propensity score- sent the predilection for a subject to be placed on extracorporeal
based matching process was then used to match ECPR and CCPR assistance. Propensity scores in both groups were shown as box
patients to obtain two groups with equalized pre-arrest charac- plots.
teristics in order to simulate the characteristics of a randomized Patients with lower and higher propensity scores were excluded
trial. from further analysis if an appropriate match could not be found.
798 J.-W. Lin et al. / Resuscitation 81 (2010) 796–803
Fig. 1. Flow chart for IHCA selection over a 36-month period. Panel A: Inclusion criteria for the conventional cardiopulmonary resuscitation group. Abbreviations: IHCA:
in-hospital cardiac arrest; CPR: cardiopulmonary resuscitation; CCPR: conventional CPR; ROSC: return of spontaneous circulation. Panel B: Inclusion criteria for the
extracorporeal-assisted CPR group. Abbreviations: ECPR: extracorporeal-assisted CPR; ROSB: return of spontaneous beating.
Table 1
Baseline Characteristics of the ECPR group with ROSB (group E-rosb) and the con-
ventional CPR group with ROSC (group C-rosc).
N 55 63
Sex
Male, n (%) 47 (85.5) 41 (65.1) 0.011
Age (year)
Mean (SD) 59.0 (11.7) 60.6 (12.7) 0.463
Median (range) 62.3 (21–73) 65.0 (22–75) 0.229
Age >60 years, n (%) 34 (61.8) 40 (63.3) 0.851
Pre-existing comorbidity
Diabetes mellitus 21 (38.2) 19 (30.2) 0.358
Hypertension 29 (52.7) 30 (47.6) 0.580
Dyslipidemia 10 (18.2) 2 (3.2) 0.012
Malignancy 5 (9.1) 15 (13 3) 0.769
Lung insufficiency 2 (3.6) 5 (7.9) 0.447
Stroke 10 (18.2) 6 (9.5) 0.171
Chronic renal disease 5 (9.1) 10 (15.9) 0.270
Cardiovascular disease 35 (63.6) 30 (47.6) 0.081
Chronic hepatitis 2 (3.6) 6 (9.5) 0.281
Causes of arrest
ACS 36 (65.5) 46 (73.0) 0.022
Congestive heart failure 4 (7.3) 9 (14.3)
Myocarditis 3 (5.5) 1 (1.6)
Post-cardiotomy 7 (12.7) 0
Pulmonary embolism 1 (1.8) 0
Unspecified cardiac causes 3 (5.5) 7 (11.1)
Initial rhythm
VT/VF 28 (50.9%) 26 (41.3%) 0.360
PEA 15 (27.3%) 25 (39.7%)
Asystole 12 (21.8%) 12 (19.0%)
Department type
Internal medicine 35 (63.6%) 45 (71.4%) 0.205
Surgery 20 (36.4%) 16 (25.4%)
Other 0 2 (3.2%)
IE before CPR
n (%) 51 (92.7) 21 (39.6) <0.001
Mean (SD) 54 (66.6) 25.0 (20.3) 0.366
Median (range) 40 (0–324) 19.1 (4.6–73)
Table 2
CPR and post-CPR variables in the E-rosb group (group E) and C-rosc group.
N 55 63
ROSC (ROSB) 55 (100) 63 (100) 1
Witnessed (%) 55 (100) 63 (100) 1
Defibrillationa , * 55 (100) 43 (68.2) <0.001
Event of location
ICU/OR/Cath lab 31 (56.4) 24 (38.1) 0.104
ER/ward 24 (43.6) 38 (60.3)
Others 0 1 (1.6)
Subsequent intervention
Any of the following 35 (63.6) 14 (22.2) <0.001
Revascularization 26 (47.3) 6 (9.5) <0.001
VAD 2 (3.6) 0 0.215
HTx 4 (7.3) 0 0.044
ECMO – 3 (14.2)
Others 9 (16.4) 6 (9.5)
Valve replacement 3, SVR 2 Tapping 3, pacing 2, DAA graft1
Table 3
Outcome of the E-rosb group and C-rosc group.
N 55 63
Table 4
Clinical characteristics and outcomes in propensity-score matched cases.
CPR duration
(min, mean ± SD) 41.8 ± 19.8 40.0 ± 26.4 0.781
Male 77.8% 85.2% 0.484
Initial rhythm 0.817
VT/VF 55.6% 66.7%
PEA 25.9% 22.2%
Asystole 18.5% 11.1%
Cumulative survival
1 day 19 (70.4%) 16 (59.3%) 0.393
3 days 14 (51.9%) 14 (51.9%) 1.000
7 days 12 (44.4%) 11 (40.7%) 0.783
One month 9 (33.3%) 7 (25.9%) 0.551
6 months 8 (29.6%) 4 (14.8%) 0.327
One year 6 (22.2%) 3 (11.1%) 0.467
Neurological outcomes
CPC status at discharge (n, %) 0.460
1 or 2 7 5
3 or 4 1 0
CPC status at one year (n, %) 0.427
1 or 2 5 3
3 or 4 1 0
was 0.4797 ± 0.2219 in the ECPR group and 0.4909 ± 0.2277 in the vival analysis trimmed at 30 days did not show a survival difference
matched CCPR group (p = 0.984) (Fig. 2B). (HR: 0.856, p = 0.634, 95% CI: 0.453–1.620). There was no survival
difference at 6 months (HR: 0.588, p = 0.089, 95% CI: 0.319–1.084)
3.4. Primary endpoint and at one year (HR: 0.602, p = 0.093, 95% CI: 0.333–1.088) (Fig. 3).
9. Danciu SC, Klein L, Hosseini MM, Ibrahim L, Coyle BW, Kehoe RF. A predic- the American Heart Association, the European Resuscitation Council, the Heart
tive model for survival after in-hospital cardiopulmonary arrest. Resuscitation and Stroke Foundation of Canada, the Australian Resuscitation Council, and the
2004;62:35–42. Resuscitation Councils of Southern Africa. Resuscitation 1997;34:151–83.
10. de Mos N, van Litsenburg RR, McCrindle B, Bohn DJ, Parshuram CS. Pediatric in- 19. Shih CL, Lu TC, Jerng JS, et al. A web-based Utstein style registry sys-
intensive-care-unit cardiac arrest: incidence, survival, and predictive factors. tem of in-hospital cardiopulmonary resuscitation in Taiwan. Resuscitation
Crit Care Med 2006;34:1209–15. 2007;72:394–403.
11. Thiagarajan RR, Laussen PC, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal 20. Haviland A, Nagin DS, Rosenbaum PR. Combining propensity score matching
membrane oxygenation to aid cardiopulmonary resuscitation in infants and and group-based trajectory analysis in an observational study. Psychol Methods
children. Circulation 2007;116:1693–700. 2007;12:247–67.
12. Chen YS, Chao A, Yu HY, et al. Analysis and results of prolonged resuscitation in 21. Ahmed A, Zannad F, Love TE, et al. A propensity-matched study of the association
cardiac arrest patients rescued by extracorporeal membrane oxygenation. J Am of low serum potassium levels and mortality in chronic heart failure. Eur Heart
Coll Cardiol 2003;41:197–203. J 2007;28:1334–43.
13. Chen YS, Yu HY, Huang SC, et al. Extracorporeal membrane oxygenation sup- 22. Scaife ER, Connors RC, Morris SE, et al. An established extracorporeal membrane
port can extend the duration of cardiopulmonary resuscitation. Crit Care Med oxygenation protocol promotes survival in extreme hypothermia. J Pediatr Surg
2008;36:2529–35. 2007;42:2012–6.
14. Chen YS, Lin JW, Yu HY, et al. Cardiopulmonary resuscitation with assisted extra- 23. Liden H, Wiklund L, Haraldsson A, Berglin E, Hultman J, Dellgren G. Temporary
corporeal life-support versus conventional cardiopulmonary resuscitation in circulatory support with extra corporeal membrane oxygenation in adults with
adults with in-hospital cardiac arrest: an observational study and propensity refractory cardiogenic shock. Scand Cardiovasc J 2008;December:1–7 [Epub
analysis. Lancet 2008;372:554–61. ahead of print].
15. Nagao K, Hayashi N, Kanmatsuse K, et al. Cardiopulmonary cerebral resuscitation 24. Chen JS, Ko WJ, Yu HY, et al. Analysis of the outcome for patients experiencing
using emergency cardiopulmonary bypass, coronary reperfusion therapy and myocardial infarction and cardiopulmonary resuscitation refractory to conven-
mild hypothermia in patients with cardiac arrest outside the hospital. J Am Coll tional therapies necessitating extracorporeal life support rescue. Crit Care Med
Cardiol 2000;36:776–83. 2006;34:950–7.
16. American heart association guidelines for cardiopulmonary resuscitation and 25. Chen YS, Ko WJ, Chi NH, et al. Risk factor screening scale to optimize treat-
emergency cardiovascular care. Circulation 2005;112:IV1–203. ment for potential heart transplant candidates under extracorporeal membrane
17. International consensus on cardiopulmonary resuscitation and emergency car- oxygenation. Am J Transpl 2004;4:1818–25.
diovascular care science with treatment recommendations. Part 4: advanced life 26. Abella BS, Alvarado JP, Myklebust H, et al. Quality of cardiopulmonary resusci-
support. Resuscitation 2005;67:213–47. tation during in-hospital cardiac arrest. JAMA 2005;293:305–10.
18. Cummins RO, Chamberlain D, Hazinski MF, et al. Recommended guidelines 27. Abella BS, Edelson DP, Kim S, et al. CPR quality improvement during in-hospital
for reviewing, reporting, and conducting research on in-hospital resuscitation: cardiac arrest using a real-time audiovisual feedback system. Resuscitation
the in-hospital ‘Utstein style’. A statement for healthcare professionals from 2007;73:54–61.